Important Notice Regarding Inveltys

Posted in Latest News on February 11, 2019.

During the February 8, 2019 Board of Optometry meeting, the board approved Inveltys (loteprednol etabonate ophthalmic suspension) 1% for addition to Rule 64B13-18.002, F.A.C. Formulary of Topical Ocular Pharmaceutical Agents.

Important note: At this time, Inveltys cannot be prescribed by certified Optometrists in Florida until the rule has been approved. Once the rule has gone through the approval process, notice will be provided on the board website and Inveltys may be prescribed by certified optometrists at that time.



More Latest News

Florida Jurisprudence CE Requirement
February 11, 2019

The Board of Optometry voted to waive the 2-hour Florida Jurisprudence requirement for all out-of-state licensees for the current biennium only. Click Here for more information. Continue reading


Important Notice Regarding Inveltys
February 11, 2019

The Board approved Inveltys (loteprednol etabonate ophthalmic suspension) 1% for addition to Rule 64B13-18.002, F.A.C. Formulary of Topical Ocular Pharmaceutical Agents Continue reading